AstraZeneca has reported the first clinical data with its oral PCSK9 inhibitor AZD0780, playing catch-up with rival MSD.

Orrville, Ohio-based Smucker said that it also will remove synthetic dyes from foods sold to K-12 schools by the 2026-2027 school year. Smucker said the majority of its products — including its ...